I-M-150847, a novel GLP-1 and GIP receptor dual agonist, improves glycemic control and reduces obesity in the rodent model of type 2 diabetes and obesity
Preprint
Abstract
We report the discovery of a novel glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor dual agonist that shows balanced agonism towards both the incretin receptor. The dual agonism of GLP-1 and GIP receptor was achieved by replacing the tryptophan cage of exendin-4 with the C-terminal undecapeptide sequence of oxyntomodulin along with a single amino acid substitution from histidine to tyrosine at the amino terminus of the peptide. The structural modification places lysine 30 of the novel incretin agonist in frame with the corresponding lysine residue in the native GIP sequence. The novel incretin agonist, named I-M-150847, promotes robust glucose-stimulated insulin exocytosis in cultured pancreatic beta cells. Chronic administration of I-M-150847 to mice fed on the high-fat diet improves glucose tolerance, decreases food intake, decreases visceral adiposity and body weight gain demonstrating its therapeutic potential in ameliorating type 2 Diabetes and Obesity. Significance statement Replacement of the Trp-cage with the C-terminal oxyntomodulin undecapeptide along with the tyrosine substitution at the amino terminus converts the selective GLP-1R agonist exendin-4 to a novel GLP-1R and GIPR dual agonist. The GLP-1R and GIPR dual agonist enhances insulin secretion, improve glucose tolerance, reduces food intake, and decreases visceral adiposity and body-weight gain in the rodent model of diabetes and obesity.Keywords
All Related Versions
- Published version: American Journal of Physiology-Cell Physiology, 327 (1), C74.
This publication has 58 references indexed in Scilit:
- Unraveling oxyntomodulin, GLP1's enigmatic brotherJournal of Endocrinology, 2012
- Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 ReceptorJournal of Biological Chemistry, 2010
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in MiceDiabetes, 2009
- Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular DomainJournal of Biological Chemistry, 2008
- Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptorProceedings of the National Academy of Sciences, 2007
- Efficacy and Safety of Incretin Therapy in Type 2 DiabetesJAMA, 2007
- The biology of incretin hormonesCell Metabolism, 2006
- Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptorsDrug Discovery Today, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Importance of Environment in Determining Secondary Structure in ProteinsBiochemistry, 1994